This post was originally published on this site

  Sanofi Pasteur is betting big on its pact with mRNA biotech Translate Bio as it deepens its ties and commitment to infectious disease vaccines using this new tech. Read more.

The post Sanofi spends $425M to double down on Translate Bio mRNA pact, eyes Q4 COVID-19 vax start appeared first on Atlas Venture.